Panome Bio provides biomarker and mechanism discovery through Next-Generation Metabolomics, proteomics, transcriptomics, and integrated multi-omics analysis. Powered by a proprietary bioinformatics pipeline, we unlock complex biological insights, driving advancements in disease research, personalized medicine, and bioprocessing systems. Panome Bio, a leader in the biotech industry, empowers researchers and clinicians to explore the molecular intricacies of life.
Pacira BioSciences, Inc.
Pacira BioSciences, Inc. is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.
Pace Life Sciences
Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, regulatory compliance consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries. Our network of CDMO sites consists of GMP analytical testing laboratories, and manufacturing support service centers. Our experienced, highly trained industry experts, and our investment in state-of-the-art development and manufacturing facilities emphasize our commitment to efficiently advancing client programs through the clinic to commercialization. At Pace, we are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business. You can find out more at pacelifesciences.com. | Pace® Life Sciences offers a comprehensive suite of contract services—including CMC development, clinical trial material (CTM) manufacturing, regulatory consulting, and facility support—for the pharmaceutical, biopharmaceutical, and gene therapy industries. With a nationwide network of CDMO sites, GMP analytical labs, and support centers, we are positioned to move your program efficiently from early development through commercialization. Our expert teams and investment in state-of-the-art facilities reflect our commitment to providing reliable, high-quality services and a seamless client experience at every stage. Pharmaceutical Development Services Our development labs offer IND-enabling support to advance therapies through preclinical stages, including the characterization of: Small molecules Biologics (proteins, peptides, antibodies, ADCs) Gene therapies (e.g., oligonucleotides) Early-Phase Development Services: Lyophilization and spray-drying process development Analytical method development and validation Test article preparation CTM manufacturing and packaging Technology transfer to our GMP facilities ensures a smooth progression from preclinical through commercial phases, in full compliance with regulatory standards. Integrated Services to Support Your Entire Lifecycle Pharmaceutical Development Preformulation & formulation development Bioavailability enhancement Clinical supplies manufacturing: Sterile products Tablets, capsules Solutions, suspensions Semi-solids, creams, ointments Clinical packaging Analytical development and method validation Solid-state API characterization Nitrosamine risk assessment Extractables/leachables testing Stability storage & testing GMP Laboratory & Commercial Support Raw materials clearance In-process and finished product testing ICH stability programs Reference standard management Elemental impurities & physical testing Microbiological testing Facility Services Commissioning & qualification Utility & equipment validation Lab relocations Consulting Services Regulatory strategy and agency interaction Quality and compliance consulting Flexible Service Models and Commitment to Quality Capacity: We support clients of all sizes with adaptable engagement models, including fee-for-service, dedicated resources, FTE programs (on-site or at client locations), ensuring cost-effective solutions. Quality: Our facilities have a strong track record of successful inspections by regulatory agencies and clients, delivering the high-quality data needed to move your program forward. Reliability: Our integrated approach ensures your program stays on schedule—on time and on budget. | Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries. Our network of CDMO sites consists of GMP analytical testing laboratories, and manufacturing support service centers. Our experienced, highly trained industry experts, and our investment in state-of-the-art development and manufacturing facilities emphasize our commitment to efficiently advancing client programs through the clinic to commercialization. At Pace, we are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business. You can find out more at pacelifesciences.com.
Ozolea Rete Agricola
OZOLEA promote non-withdrawal strategies for udder issues management in dairy cattle.
Owkin
Owkin is an Agentic AI company pioneering the use of data, biology, and AI to decode the fundamental mechanics of disease and advance medical science. By focusing on the system’s ability to uncover biology’s ground truth at scale, Owkin aims to revolutionize the way we diagnose and treat diseases. With a vision of achieving a “positive singularity” in medicine, Owkin leverages AI to deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional pharmaceutical approaches often cannot solve. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research across nine cancer indications. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like F-Prime, GV and Bpifrance, among others.
OVIAL Nutrition
The Ovial Nutrition Kit is a complete 6-week nutritional system developed by surgeons to support orthopedic patients throughout their recovery journey. Designed to help prepare the body before surgery and optimize healing afterward, OVIAL focuses on the core biological needs of recovery: muscle preservation, inflammation support, tissue repair, nerve health, mobility, immune balance, and improved sleep quality.
Osteal Therapeutics
Osteal Therapeutics is a privately held, clinical-stage biopharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences. The company is leveraging the ability of concentrated, locally delivered antimicrobials to treat the bacterial biofilms typically responsible for musculoskeletal infections while minimizing off-target tissue exposure and associated adverse effects. Osteal employs a low-risk development strategy by using approved drugs with long histories of safety and efficacy as candidates for new routes of local delivery. The company’s lead candidate, VT-X7 KIT, is in late-stage clinical development to treat periprosthetic joint infections, a serious complication of joint replacement surgery. For more information, please visit: www.ostealtx.com.
Onbe
The payouts gateway that enables clients to outsource their entire B2C disbursement operation, relieving them of the cost, complexity and risk that come with orchestrating these payments in-house, delivering context-driven payment choices that are instant, convenient and simple. | Onbe enables health-tech platforms and banks launch digital patient refunds that differentiate their offering, reduce operational and compliance risk and scale provider adoption.
Ocular Therapeutix
Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across development, treatment, and outcomes. OTX-TKI (also known as AXPAXLI™), Ocular’s investigational product candidate for retinal disease, is an axitinib intravitreal hydrogel based on its ELUTYX™ proprietary bioresorbable hydrogel-based technology. It is currently in Phase 3 clinical trials to advance wet age-related macular degeneration (AMD) and diabetic retinopathy (DR) treatment, aiming to improve long-term outcomes while reducing the frequency of injections. | Ocular Therapeutix, Inc. is a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and other eye conditions.
Oakwood Labs
Oakwood Labs is a specialized contract development and manufacturing organization (CDMO) focused on advanced drug delivery, with particular expertise in long-acting injectable (LAI) technology. The company develops and manufactures biodegradable polymer-based formulations—primarily using PLGA microspheres—that enable sustained, controlled release of small molecules, peptides, and proteins ranging from days up to a year. Leveraging deep scientific know-how and proprietary formulation platforms, Oakwood Labs supports pharmaceutical partners from early-stage development through commercial manufacturing. Its integrated CMO capabilities include formulation development, analytical services, scale-up, aseptic fill-finish, and regulatory support, making it a trusted partner for complex parenteral products that require precision, consistency, and extended-release performance.